Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of Myelodysplastic Syndrome Read more
Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated lung cancer Read more
Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the treatment of COVID-19 Read more
Menarini Silicon Biosystems launches new breakthrough DEPArray PLUS image-based cell sorter to isolate rare cells with single cell precision Read more
Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis (ALS) Read more
Transgene and BioInvent Receive IND Approval from the U.S. FDA for BT-001, a Novel Oncolytic Virus for the Treatment of Solid Tumors Read more
NiKang Therapeutics Announces Completion of $200 Million Series C Financing to Advance Highly Differentiated Small Molecules Addressing Difficult-to-Drug Targets Read more
Pieris Pharmaceuticals Announces Respiratory and Ophthalmology Collaboration with Genentech Read more